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Abstract 
 
Objective: Seizures can cause vestibular symptoms, even without obvious epileptic features. 
We sought to characterize epileptic vertigo or dizziness (EVD) to improve differentiation 
from non-epileptic causes, particularly when vestibular symptoms are the sole manifestation.  
 
Methods: Systematic review with electronic (MEDLINE) and manual search for English-
language studies (1955-2014). Two independent reviewers selected studies. Study/patient 
characteristics were abstracted. We defined three study-population types: (1) seizures, some 
experiencing vertigo/dizziness (disease cohort); (2) vertigo/dizziness, some due to seizures 
(symptom cohort); (3) vertigo/dizziness due to seizures in all patients (EVD-only cohort). 
 
Results: We identified 84 studies describing 11,354 patients (disease cohort=8,129; symptom 
cohort=2,965; EVD-only cohort=260). Among 1,055 EVD patients in whom a distinction 
could be made, non-isolated-EVD was present in 8.5%, isolated-EVD in 0.8%. Thorough 
diagnostic workups (ictal EEG, vestibular testing, and brain MRI to exclude other causes) 
were rare (<0.1%). Ictal EEG was reported in 487 (4.3%), formal neuro-otologic assessment 
in 1,107 (9.7%). Localized EEG abnormalities (n=350), were most frequently temporal 
(79.8%) and uncommonly parietal (11.8%). Duration of episodic vestibular symptoms varied, 
but was very brief (<30sec) in 69.6% of isolated-EVD and 6.9% of non-isolated-EVD.  
 
Conclusions: Non-isolated-EVD is much more prevalent than isolated-EVD, which appears 
to be rare. Diagnostic evaluations for EVD are often incomplete. EVD is primarily associated 
with temporal-lobe seizures; whether this reflects greater epidemiologic prevalence of 
temporal-lobe seizures or a tighter association with dizziness/vertigo presentations than with 
other brain regions remains unknown. Consistent with clinical wisdom, isolated-EVD spells 
often last just seconds, although many patients experience longer spells.  
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INTRODUCTION 
Vertigo (defined as a sensation of self-motion when no self-motion is occurring or as the 
sensation of distorted self-motion during an otherwise normal head movement)1 or dizziness 
(defined as a sensation of disturbed or impaired spatial orientation without a false/distorted 
sense of motion)1 are common symptoms, often reported by patients known to suffer epileptic 
seizures. These vestibular symptoms may be related to the seizure itself (i.e., representing an 
aura symptom), to side effects of antiepileptic drug therapy, or may be linked to a second, 
comorbid non-epileptic disorder (e.g., vestibular migraine). Those with episodic vestibular 
symptoms deemed to result directly from focal, intermittent epileptic discharges have been 
variously known as epileptic vertigo,2 vestibular epilepsy,3 vestibular seizures,4 vertiginous 
seizures4-6 or epilepsia tornado.7 In this manuscript we use the more inclusive term ‘epileptic 
vertigo or dizziness’ (EVD). 
Seminal work by Penfield and Jasper established the scientific basis for understanding 
the pathophysiology of EVD.8 By means of surface electrical stimulation, they elicited 
illusionary transient sensations of rotation, translation, or undirected motion in their patients, 
mapping the extent of the vestibular cortex and demonstrating that seizures cause 
vertigo/dizziness because they lead to hyperactivity in vestibular cortical areas. They 
described EVD during both temporal and parietal lobe stimulation. These cortical areas were 
confirmed by Kahane,9 reporting vestibular sensations after electrical stimulation centered 
around a lateral cortical temporo-parietal area, known as the temporo-peri-Sylvian vestibular 
cortex. Less frequently, Kahane found vestibular sensations by stimulating within the 
occipital, frontal, and insular cortex. Congruent but somewhat more expansive than these 
experimentally-derived results, epileptic discharges on ictal electroencephalography (EEG) in 
symptomatic EVD were individually localized to frontal,2 fronto-temporal,10 temporal,11, 12 
temporo-parieto-occipital13 and parietal14 areas, suggesting either processing of vestibular-
related input across large cortical regions15 or spread of excitation to or from nearby regions. 
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Lesion studies in humans provide additional insights into the extent of cortical networks 
processing of vestibular/graviceptive inputs. Insular and parietal lesions dominate the 
literature on vertigo/dizziness from stroke,16 including the seminal study of Brandt, reporting 
shifts in perceived verticality in lesions affecting the posterior insula.17 
The differential diagnosis for isolated episodic vertigo/dizziness is broad and cuts 
across medical specialties, including neurology (vestibular migraine, transient ischemic 
attack, seizures), otolaryngology (Menière’s disease, vestibular paroxysmia), internal 
medicine (hypoglycemia), cardiology (arrhythmia), and psychiatry (panic attacks), so 
knowing when (or when not) to consider EVD would be helpful. When obvious seizure-
related symptoms or signs (e.g., a generalized convulsion) accompany vestibular symptoms, 
EVD is readily recognized. EVD causing isolated vestibular symptoms was reported,2, 18, 19 
but there is limited information about prevalence and clinical characteristics (e.g., 
accompanying symptoms, duration) that might help distinguish it from non-epileptic causes.  
 We performed a systematic review of studies reporting on (a) vestibular symptoms in 
seizure patients (disease cohort), (b) seizures in vestibular patients (symptom cohort), and (c) 
clinical details in reports of patients with EVD (EVD-only cohort). The aim of this work was 
to better characterize the prevalence of non-isolated EVD (ni-EVD) and isolated EVD (i-
EVD) in adults and children, seizure localization, and episode duration. 
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MATERIAL AND METHODS 
 
A MEDLINE search was performed (04/2014) to identify articles reporting on EVD using 
terms related to seizures/epilepsy and vertigo/dizziness. Both retrospective and prospective 
case series and single case reports were eligible. Studies sought for reported on the 
differential diagnosis of dizzy patients or on aura symptoms in patients with a given type of 
epilepsy. Specific search terms and inclusion/exclusion criteria can be found in the online 
supplement (Appendix e-1). We identified 1,137 electronic citations for screening and 
included 84 studies (Appendix e-1 – flow-chart). When extracting the data from the selected 
studies, we assessed the type of the study, whether the vestibular symptoms were isolated or 
accompanied by other seizure symptoms, the duration of EVD episodes, and EEG findings. In 
all EVD patients we rated the quality of EEG and vestibular assessment and the quality of the 
association between seizures and vertigo/dizziness (table 1). 
 
A single expert epileptologist (PWK) assessed all published EEG recordings from the 
included studies for quality to establish a definitive diagnosis of EVD. Seizure location and 
laterality was retrieved where EEG recordings were available and were coded as temporal, 
parietal, occipital, or frontal in origin. If the reported seizure location was linked to more than 
one of these areas (e.g., fronto-temporal), a count was given to each lobe for calculating the 
relative frequency of discharges in different lobes. 
 
  
7   
RESULTS 
Demographic information 
Eighty-four studies reporting on 11,354 patients matched the inclusion criteria (online 
supplement, Appendices 2&3). The majority of these 84 studies were retrospective case series 
(n=52, 61.9%) or single cases (n=26, 31.0%) (online supplement, Appendix e-3, Table e-1). 
The remaining six studies were prospective (n=5, 6.0%) or ambispective (n=1, 1.2%) case 
series. Retrospective case series were the most frequent study type both in the disease (81.1%, 
study size=1-1563 patients) and the symptom (83.3%, study size=8-907 patients) cohort, 
while prospective case series were rare in either cohort (disease cohort: 8.1%, study size=3-
1897; symptom cohort: 11.1%, study size=70-142). Overall, 71.6% of patients were in the 
disease cohort, while 26.1% were in the symptom cohort. The remaining 2.3% fulfilled 
criteria for the EVD-only cohort (Table 1). The distribution of adult and pediatric patients 
among the cohorts was distinct: 69% of all adults belonged to the disease cohort; 87% of all 
children were part of the symptom cohort. Various other diagnoses were reported in 2,499 
patients (Table 2).  
 
Diagnostic Testing 
EEG-findings were reported in 50.9% of patients. Surface recordings were available in 
50.1%, intracranial recordings in 2.7%. We judged the quality of EEG assessment based on 
the presence/absence of EEG-documented seizures and clinical findings during these seizures. 
A “high” quality (ictal) EEG assessment was found in 4.3%, a “medium” quality (interictal) 
EEG assessment in 46.6%. In 49.1% the electrographic assessment was considered “low” 
quality, and the diagnosis of seizures was made on the clinical history alone (Table 3).  
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Neuroimaging was available in 13.7%, vestibular testing in 26.3% (Table 3). In many of these 
patients, results from vestibular testing were not reported and only in four patients (0.04%) 
complete vestibular testing was accompanied by ictal EEG and MRI. 
 
Fraction of patients with ni-EVD and i-EVD 
From 11,354 patients included (disease cohort=8,129; symptom cohort=2,965; EVD-only 
cohort=260), 1,055 patients (9.3%) had EVD, and were coded as ni-EVD (n=967, 8.5% of 
total) or i-EVD (n=88, 0.8% of total) (Table 4). Of all EVD patients, 64.7% were in the 
disease cohort, 10.7% were in the symptom cohort. The frequency for diagnosing i-EVD or 
ni-EVD was about twofold greater for patients in the disease cohort (683/8,129, 8.4%) 
relative to the symptom cohort (113/2,965, 3.8%). 
In the study sample, the overall fraction of EVD in children (73/687, 10.6%) and 
adults (300/3132, 9.6%) was similar, but the distribution was heterogeneous across study 
cohorts. In the symptom cohort, EVD was diagnosed nearly 9-fold more often in children 
(52/596, 8.7%) than in adults (9/920, 1.0%); by contrast, in the disease cohort, EVD was 
diagnosed just 1.3-fold more often in children (11/70, 15.7%) than adults (253/2162, 11.7%).  
 
Quality of the association between epilepsy and vertigo/dizziness 
From all EVD patients, a high-quality association was found in 4.1% (43/1,055), while 
medium (512/1,055, 48.5%) or low (500/1,055, 47.4%) quality was noted in the remaining 
95.9%. Published EEG traces from EVD cases (n=33) were reviewed. From the 14 EEG 
recordings originally rated as ictal, this was confirmed in 11, while in two cases19, 20 the EEG 
data presented was only “probably” consistent with an ongoing seizure and in one case21 no 
seizure was depicted. Diagnosis in the remaining 19 cases (interictal EEG changes) was 
confirmed. 
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 Seizure location 
Results from ictal/interictal EEG recordings were available in 580 EVD patients (Table 5). 
EEG seizure locations (n=350) were assigned as described in the Methods. Since more than 
one location was reported in 73 patients, the total count (n=391) exceeded the number of EVD 
patients with localized EEG changes. The most frequent location was temporal (79.8%); 
parietal (11.8%), occipital (5.4%), and frontal (3.1%) seizures were found in small fractions.  
 
Lateralization of focal EEG changes 
From the 350 EVD cases with localized EEG changes, the side of the EEG focus was reported 
in 126 (36.0%). Right-hemisphere (n=51) and left-hemisphere (n=57) seizure foci occurred 
with similar frequency (40.5% vs. 45.2%, Fisher’s exact p=0.50). In 18 cases a bihemispheric 
focus was observed. In ni-EVD (n=86; 10 bilateral foci), right- and left-hemisphere foci had 
identical frequency (n=38, 44.2% each). For i-EVD (n=40; 8 bilateral foci), left-hemispheric 
foci were slightly more frequent than right-hemispheric foci (19 vs. 13; 47.5% vs. 32.5%, 
p=0.21). 
For cases with information on sidedness of focal EEG changes (n=126) we assessed 
laterality by seizure location (total of 163 locations recorded). There were clinically-
meaningful but not statistically-significant differences in sidedness based on the seizure 
location (Right% [n] vs. Left% [n]): (1) temporal (37.8% [37] vs. 44.9% [44], p=0.35); (2) 
parietal (59.0% [23] vs. 35.9% [14], p=0.06); (3) occipital (62.5% [10] vs. 25% [4], p=0.06); 
and (4) frontal (30.0% [3] vs. 70.0% [7], p=0.18).  
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Duration of EVD and effect of treatment 
Specific numbers on EVD duration were available in 108 patients (Table 5). Comparing i-
EVD and ni-EVD cases, brief spell duration (≤30sec) was noted in a much larger fraction in i-
EVD cases than ni-EVD cases (69.6% vs. 6.9%, p<0.001). 
 
Effect of treatment with various antiepileptic drugs (AED) was reported in 110 patients 
(10.4%), with 90.0% considered responders. Among responders with details on drug 
treatment (n=54), phenytoin (n=16), carbamazepine (n=12) and valproate (n=5) were applied 
most often (online supplement, Appendix e-3, Table e-2). 
 
Type of vestibular and accompanying seizure symptoms 
A majority of studies did not provide definitions of the terms used to describe the vestibular 
spells (9,506 patients, 83.7%), including “vertigo” or “vertiginous” (6,302, 55.5%), 
“dizziness” (93, 0.8%) and “vertigo or dizziness” (3,114, 27.4%). Definitions for vertigo and 
dizziness were provided in 9 studies (vertigo=304 patients [2.7%], dizziness=2 patients 
[0.2%]) (online supplement, Appendix e-1). In three studies (1,539, 13.6%), the four 
categories brought forward by Drachman and Hart22 (dizziness vs. vertigo vs. lightheadedness 
vs. faintness) were used. From the 1,055 EVD patients, definitions for vertigo (n=135, 12.8%) 
and dizziness (n=2, 0.2%) were provided in 137. Information about other seizure 
symptoms/signs occurring in the same epileptic attack could be retrieved from 171 EVD 
patients (Table 6).  
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DISCUSSION 
Our systematic review of EVD in the medical literature offers quantitative confirmation for 
the clinical intuition that EVD is uncommon, and isolated EVD is rare (although it is probably 
more prevalent in children presenting vestibular symptoms than in adults). It further confirms 
that, when EVD is isolated, episodes are most often very brief (lasting seconds), although our 
results also suggest that longer episodes (lasting minutes) are not uncommon. This study 
suggests two other findings that are somewhat unexpected: (1) epileptic foci causing EVD are 
much more likely to be temporal than parietal, and (2) they are equally likely to originate in 
the right and left hemispheres. These results may assist clinicians in determining whether their 
patients presenting vertigo or dizziness should be evaluated for seizures and whether those 
with epilepsy require further vestibular assessment. 
EVD Prevalence in Adults and Children 
We cannot draw strong inferences about the incidence or prevalence of EVD in the general 
population, but our data do offer some insights into the epidemiology of EVD. First, ni-EVD 
appears to be uncommon in both symptom (3.7%) and disease (8.0%) cohorts; since some of 
these might have actually been missed co-morbid vestibular disorders (see below), and studies 
not reporting vertigo/dizziness in epilepsy or epilepsy in dizziness (i.e., with lower 
prevalence) would not have been captured by our search, these numbers are probably 
plausible upper limits for the frequency of EVD in dizziness and in epilepsy. The higher 
prevalence of ni-EVD in the disease cohort makes intuitive sense (i.e., known seizure patients 
are more likely to have epileptic dizziness than patients evaluated for dizziness). 
Second, i-EVD is probably rare in both dizziness (0.1%) and in epilepsy (0.4%). It is 
not surprising that i-EVD would be much less common than ni-EVD. Although this difference 
could be attributed to diagnostic ascertainment bias,23 it seems plausible that i-EVD is, 
indeed, substantially less common in both symptom and disease cohorts. Again, because our 
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search strategy was skewed towards studies seeking EVD in dizziness, these estimates 
probably represent plausible upper bounds, although we cannot be sure that more rigorous 
diagnostic ascertainment would not have identified some missed cases. 
Third, as suggested previously, EVD may be more common in children than in 
adults.24 This claim is supported by our finding of a higher frequency of EVD in children 
relative to adults in our symptom cohort (ratio children:adults, 8.7:1), which suggest that EVD 
probably accounts for a greater fraction of vertigo/dizziness presentations in children than 
adults (or at least that EVD is a more frequent focus of diagnostic inquiry and publication in 
pediatric populations). For the disease cohort, EVD was diagnosed with roughly equal 
frequency (ratio children:adults, 1.1:1), indicating that seizures, when present, are about 
equally likely to produce vertigo/dizziness in children and adults (although this finding must 
be viewed cautiously given the small number of children relative to adults in this cohort –70 
vs. 2,162). These findings suggest that it is not a biological interaction with age (e.g., seizures 
in a young brain are more likely to produce dizziness), but an epidemiologic one. In other 
words, the proportion of dizziness cases due to EVD is probably higher in children than adults 
based on different population distributions of etiologies for dizziness in children vs. adults. 
This could be because seizures are more common in children, other causes (e.g., BPPV, 
stroke) are more common in adults, or a combination of both. 
 
Seizure Location and Lateralization 
A critical role of temporal areas in self-motion perception has been previously proposed based 
on functional-MRI studies during caloric irrigation,25 case reports with focal lesions within 
the temporal gyrus26, 27 and transcranial magnetic stimulation over the superior temporal 
gyrus.28 Illusionary sensations of self-motion can be elicited by cortical electrical stimulation 
within a fairly large area including temporal and parietal lobes, but also, less frequently, 
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occipital and frontal lobes8 and may include sensations of rotation in different planes, 
translations and indefinable body motion.9 The high frequency of temporal over parietal lobe 
seizure location in our review does not reflect the distribution noted in these electrical 
stimulation studies and current expert opinion. Potentially, this discrepancy is a result of the 
overall higher prevalence of temporal lobe seizures compared to parietal lobe seizures in 
epileptic patients29 and as a result, EVD is more often associated with a temporal than a 
parietal location on epidemiological, rather than biological grounds.  
Regardless, based on the distribution of seizure locations observed here, symptoms 
and signs of temporal lobe origin (e.g. rising epigastric sensations, auditory hallucinations, 
emotional/dysmnestic phenomena) should be sought in patients with suspected EVD. 
However, temporal lobe seizures may be difficult to diagnose clinically and by standard 
surface EEG,30, 31 with invasive recordings offering improved spatial resolution and increased 
sensitivity.32, 33 From our 580 EVD patients with EEG available, only a small fraction 
underwent intracranial EEG recordings. This probably suggests that, clinically, some patients 
with temporal lobe EVD remain undiagnosed because of a false-negative surface EEG. 
Previously, a right-hemisphere dominance for EVD had been proposed,34 which is a 
sensible hypothesis, given the right hemisphere’s predominant role in spatial perception. In 
our data set, however, no statistically significant differences were found. Left-hemisphere foci 
were slightly more common overall in this sample. There was, however, some heterogeneity 
based on the focus of seizure activity―a slight left-sided predominance was noted for 
temporal lobe seizures, but a relatively large (and borderline statistically significant) right-
sided predominance was noted in the subgroups with parietal and occipital lobe seizures. 
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Duration of EVD – from few seconds to several minutes 
Knowledge about the duration of vertigo/dizziness is important to narrow the differential 
diagnosis.35 Traditionally, EVD has been considered to last a few seconds only,18 and 
consequently, the clinician may have dismissed a diagnosis of EVD if spells exceeded this 
duration. In this review we found brief spells (≤1min) in 46.3% of cases. The remaining 
patients presented with spells lasting several minutes (a duration typically associated with 
vestibular migraine,36 Menière’s disease37 or episodic ataxia38) or had spells of variable 
duration. Based on our data, dizzy spells exceeding a few seconds duration and lasting up to 
several minutes should still be considered as potentially epileptic. For the i-EVD cases, the 
dictum that epileptogenic vertigo/dizziness lasts a few seconds held true with a duration of 
≤30sec in 69.6%, suggesting that the clinical presentation of seizures (isolated 
vertigo/dizziness vs. with other seizure-like symptoms) may be linked to the duration of the 
dizzy spells. It is biologically plausible that short bursts of epileptic activity would be more 
likely to produce short-lived, isolated symptoms, while longer runs of epileptic activity would 
be more likely to be sustained and spread, causing longer, non-isolated episodes of EVD. 
Interestingly, almost all cases with EVD localized to the temporal lobe (in which spell 
duration was provided), were in the range of few seconds to less than one minute, while the 
few EVD cases with non-temporal location lasted longer. This could indicate that EVD in 
temporal-lobe seizures is associated with especially brief dizzy spells. Spontaneous spells 
lasting seconds are also typical in vestibular paroxysmia,39 a condition known to be 
exquisitely carbamazepine responsive,40 so some such patients might readily be confused for 
i-EVD or vice versa, including in our series, where the quality of vestibular assessments was 
generally low. Whether a high frequency of attacks per day (as seen in some patients with 
vestibular paroxysmia)40 excludes i-EVD is unknown; the reports we reviewed described 
patients with daily or more frequent spells in only two cases.10, 41 Patients with suspected 
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vestibular paroxysmia should probably be assessed by EEG to exclude the possibility of i-
EVD as an alternative cause for brief paroxysms before treatment with carbamazepine.  
 
High rate of AED treatment response 
We found response rates to AED treatment in EVD of 90%. Some have suggested this be 
used as a diagnostic test to point to an ictal etiology in responders.18, 34 However, treatment-
response information was available only in 10% and for example, successful treatment 
strategies for vestibular paroxysmia and vestibular migraine include AEDs such as 
carbamazepine, valproate, and topiramate.40, 42 Thus, response to AED treatment in patients 
with episodic vertigo/dizziness does not prove an epileptic origin of the spells.  
 
Quality of EEG, vestibular and imaging assessment 
A thorough diagnostic workup (brain MRI plus complete vestibular testing plus ictal EEG) 
was rarely performed. In the disease cohort, only 9/34 case series placed emphasis on 
vestibular symptoms in study design,3, 6, 34, 43-48 which may explain why vestibular testing was 
infrequent in this cohort. Likewise, in the symptom cohort, seizures were just one of many 
differential diagnostic considerations, explaining a low rate of obtaining EEG.  
Incomplete workups in the disease cohort might have led to overdiagnosis of EVD 
(misattribution of dizziness from another cause to known epilepsy causing other symptoms); 
likewise, incomplete workups in the symptom cohort might have led to underdiagnosis of 
EVD. Of note, the lifetime prevalence of migraine headaches is about 2.4 times greater in 
patients with diagnosed epilepsy than in their relatives without epilepsy,49 and the lifetime 
prevalence of migraine in the epileptic population is 8-24%.49-51 Likewise, in migraine 
headache patients the lifetime prevalence of epilepsy is 1-17%,50 which is clearly higher than 
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that of epilepsy in the general population (0.6-1.5%).52 This non-chance association may have 
led to diagnostic misclassification of vestibular migraine as EVD or vice versa.  
Epileptic nystagmus 
From all EVD patients identified, only 1% presented with both EVD and epileptic nystagmus. 
This rate may be falsely low as, in most EVD patients, seizures were not observed by a 
physician and eyewitness reports of nystagmus are usually not available. The cortical areas 
associated with seizure activity leading to epileptic nystagmus spread across temporal, 
parietal and occipital lobes and are presumably related to the control of smooth-pursuit or 
saccadic eye movements.53 These seizure locations partially overlap with the mostly temporal 
locations for EVD in our systematic review. However, reviews in the literature collecting 
cases of epileptic nystagmus report rates of associated episodic vertigo/dizziness of only 
5-7%.54-56 This dissociation suggests that the cortical areas eliciting epileptic nystagmus and 
EVD are activated at the same time by an epileptic attack in only a minority of cases. If the 
clinician therefore witnesses a seizure presenting with EVD it is unlikely that he/she will 
detect nystagmus and vice versa.  
 
Conclusions 
In summary, EVD is primarily associated with temporal-lobe seizures and we found ni-EVD 
is more common than i-EVD; and i-EVD appears to be rare. Consistent with clinical wisdom, 
i-EVD spells often last just seconds, although many patients experience longer spells. 
Epileptic nystagmus is an infrequent accompaniment, despite its apparent similarity. 
Prospective diagnostic studies in unselected symptom or disease cohorts would be required to 
confirm and refine these estimates further, which are based largely on retrospective case 
series data. In the meantime, clinicians should consider EVD when assessing patients with 
17   
dizziness/vertigo, particularly children with very brief episodes or when other suspicious 
symptoms are present. 
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Tables  
Table 1: Rating of EEG and vestibular assessment and strength of association between 
seizures and vertigo/dizziness   
Quality of EEG assessment 
• High: 
o Ictal (symptomatic*) EEG recordings.  
• Medium: 
o Interictal EEG recordings. 
• Low: 
No EEG recordings noted.† 
 
Quality of vestibular evaluation 
• Complete: 
o Vestibular evaluation by a subspecialist neuro-otologist or specific description 
of vestibular testing that includes a measure of vestibulo-ocular reflex function 
(e.g., caloric tests or head impulse tests) and a search for nystagmus with 
suppression of visual fixation (e.g., Frenzel goggles) and positional tests. 
• Partial: 
o Any mention of neuro-otological testing short of “complete”. 
• None: 
o No mention of any testing for vestibular disorders. 
 
Strength of association between seizures and dizziness/vertigo 
• High: 
o Ictal EEG demonstrating epileptiform discharges at the time of 
vertigo/dizziness 
 
• Medium: 
o Episodic vertigo/dizziness with an ictal (non-vestibular symptoms) or 
interictal EEG demonstrating epileptiform discharges 
 
• Low: 
o Episodic vertigo/dizziness with a clinical diagnosis of seizures/epilepsy (no 
confirmation by EEG or no EEG obtained‡) 
 
* Ictal EEG recordings may have been taken during non-vestibular seizures 
† If the report was unclear, the quality of EEG assessment was recorded as low. 
‡ If the report was unclear, the strength of association was coded as low.  
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Table 2: characterization of study sample 
 adults children age NR total 
study cohorts     
disease cohort (seizures) 2162 70 5897 8129 
symptom cohort (dizziness / vertigo) 920 596 1449 2965 
EVD-only cohort 50 21 189 260 
all cohorts pooled 
 
3132 687 7535 11354 
imaging     
brain MRI 486 26 372 884 
brain CT 78 40 296 414 
SPECT 32 1 0 33 
modality unclear 0 55 174 229 
All brain imaging pooled 596 122 842 1560 
     
reported Dx in dizzy patients *, †, ‡     
other disorders 10 25 857 892 
benign paroxysmal positional vertigo 1 10 391 402 
Menière's disease 2 3  193 198 
psychogenic 13 24 130 167 
migraine § 7 85 56 148 
secondary to head trauma 22 104 12 138 
benign paroxysmal vertigo of childhood 0 95 4 99 
vestibular neuritis 12 20 65 97 
unresolved 15 23 55 93 
various cerebrovascular disorders 3 0 72 75 
labyrinthitis 1 53 8 62 
cerebellopontine angle tumors 4 27 4 35 
otitis media 10 5 15 30 
secondary to ototoxic substances 1 20 8 29 
multiple sclerosis 1 0 20 21 
meningitis 1 3 1 5 
perilymph fistula 1 4 0 5 
delayed endolymphatic hydrops 0 2 1 3 
all diagnoses pooled 104 503 1892 2499 
 
Abbreviations: NR = not reported 
 
* Seizures are reported separately in tables 4 and 5 
† Complete or partial vestibular evaluation was available from 29 studies. From those, specific diagnoses related to dizziness/vertigo were 
available in 12 studies (all belonging to the symptom cohort). Two other studies provided diagnoses in the dizzy patient only on the level of 
categories (peripheral-vestibular disorders, central disorders).57, 58 The results from these studies are not shown in this table. In addition, two 
patients from the disease cohort and from the combined cohort each were diagnosed with migraine.  
‡ All except 3 of those patients belonged to the symptom cohort. 
§ A diagnosis of migraine (no further distinction between migraine headaches, vestibular migraine, basilar-type migraine or other) was made 
in 148 patients; however, the criteria applied to obtain a diagnosis of migraine were not specified. From these 148 patients, 147 had both 
migraine headaches and episodic dizziness, fulfilling the current international diagnostic criteria for possible vestibular migraine.59 
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Table 3: summary of vestibular and EEG assessment 
Quality of EEG assessment     
 # patients 
High (ictal EEG) adults children age NR total 
disease cohort (IC seizures) * 150 9 314 473 
symptom cohort (IC vertigo/dizziness) † 0 0 0 0 
EVD-only cohort ‡ 7 7 0 14 
all cohorts pooled 157 16 314 487 
medium (interictal EEG)     
disease cohort (IC seizures) * 335 42 4385 4762 
symptom cohort (IC vertigo/dizziness) † 307 124 0 431 
EVD-only cohort ‡ 42 14 43 99 
all cohorts pooled 684 180 4428 5292 
low (no EEG)     
disease cohort (IC seizures) * 1717 19 1158 2894 
symptom cohort (IC vertigo/dizziness) † 755 472 1307 2534 
EVD-only cohort ‡ 1 0 146 147 
all cohorts pooled 2473 491 2611 5575 
     
Extent of vestibular assessment     
 # patients 
complete adults children age NR Total 
disease cohort (IC seizures) * 1 0 29 30 
symptom cohort (IC vertigo/dizziness) † 106 506 400 1012 
EVD-only cohort ‡ 20 15 30 65 
all cohorts pooled 127 521 459 1107 
partial     
disease cohort (IC seizures) * 48 0 0 48 
symptom cohort (IC vertigo/dizziness) † 160 69 1596 1825 
EVD-only cohort ‡ 1 0 0 1 
all cohorts pooled 209 69 1596 1874 
none     
disease cohort (IC seizures) * 4013 70 3841 7924 
symptom cohort (IC vertigo/dizziness) † 127 1 127 255 
EVD-only cohort ‡ 29 6 159 194 
all cohorts pooled 4169 77 4127 8373 
 
Abbreviations: NR = not reported 
 
* This cohort contains patients from studies that had a diagnosis of seizures as inclusion criteria (IC) and the study reported on vertigo or 
dizziness.  
 
† This cohort contains patients from studies that had dizziness or vertigo as inclusion criteria (IC) and the study reported on seizures. 
 
‡ This cohort includes patients from studies that required both the presence of vertigo or dizziness and seizures as inclusion criteria. 
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Table 4: Distribution of patients with EVD with regards to strength of association between EVD and EEG 
 # Dx of non-isolated EVD # Dx of isolated EVD # all Dx of EVD 
 strength of association* strength of association strength of association 
 high med. low all high med. low all high med. low all 
Symptom cohort 
(n=2,965) 
            
adults 0 4 5 9 0 0 0 0 0 4 5 9 
children 0 38 11 49 0 3 0 3 0 41 11 52 
age NR 0 3 48 51 0 1 0 1 0 4 48 52 
% of cohort 0.0% 1.5% 2.2% 3.7% 0.0% 0.1% 0.0% 0.1% 0.0% 1.7% 2.2% 3.8% 
Disease cohort 
(n=8,129) 
            
adults 13 69 155 237 3 13 0 16 16 82 155 253 
children 3 4 3 10 1 0 0 1 4 4 3 11 
age NR 13 262 131 406 0 13 0 13 13 275 131 419 
% of cohort 0.4% 4.1% 3.6% 8.0% 0.0% 0.3% 0.0% 0.4% 0.4% 4.4% 3.6% 8.4% 
EVD-only cohort 
(n=260) 
            
adults 2 28 1 31 2 5 0 7 4 33 1 38 
children 3 4 0 7 3 0 0 3 6 4 0 10 
age NR 0 21 146 167 0 44 0 44 0 65 146 211 
% of cohort 1.9% 20.4% 56.6% 78.8% 1.9% 18.8% 0.0% 20.8% 3.8% 39.2% 56.5% 99.6% 
all cohorts pooled             
# identified cases 
(all ages pooled) 
34 433 500 967 9 79 0 88 43 512 500 1055 
% of all cohorts 0.3% 3.8% 4.4% 8.5% 0.1% 0.7% 0.0% 0.8% 0.4% 4.5% 4.4% 9.3% 
 
Abbreviations: NR = not reported 
 
* Strength of association between EVD and EEG: 
high (dizziness or vertigo during EEG-documented seizure) 
medium (episodic dizziness or vertigo in a patient with EEG-confirmed seizures) 
low (episodic dizziness or vertigo in a patient with clinical diagnosis of seizures - may have had also normal EEG) 
all (high, medium and low combined) 
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Table 5: EEG-findings in patients with ni-EVD or i-EVD and duration of dizzy spells 
EEG-findings in EVD 
 
ni-EVD i-EVD all EVD 
number of EEGs in EVD (% all EVD cases) *    
# all EEGs  459 (47.5%) 75 (85.2%) 580 (55.0%) 
# EEGs w localized pathologies † 291 (30.1%) 43 (48.9%) 350 (33.2%) 
    
EEG seizure location (% all EEGs)    
localized EEG changes  291 (63.4%) 43 (57.3%) 350 (60.3%) 
generalized seizures 14 (3.1%) 2 (2.7%) 28 (4.8%) 
no seizure location 134 (29.2%) 29 (38.7%) 163 (28.1%) 
seizure location looked for but not found 20 (4.4%) 1 (1.3%) 39 (6.7%) 
    
breakdown EEGs w localized changes  
(% all localized EEGs) 
   
all counts w localized changes ‡ 322 (100%) 53 (100%) 391 (100%) 
temporal 256 (79.5%) 40 (75.5%) 312 (79.8%) 
parietal 41 (12.7%) 5 (9.4%) 46 (11.8%) 
occipital 16 (5.0%) 5 (9.4%) 21 (5.4%) 
Frontal 
 
9 (2.8%) 3 (5.7%) 12 (3.1%) 
duration of dizzy spells in EVD § ni-EVD i-EVD all EVD 
    
< 1 minute 4 (12.5%) 38 (82.6%) 52 (46.8%) 
≤30 seconds 2 (6.3%) 32 (69.6%) 34 (30.6%) 
30-60 seconds 2 (6.3%) 4 (8.7%) 6 (5.4%) 
no further separation possible 0 (0.0%) 2 (4.3%) 12 (10.8%) 
>1 minute 13 (40.6%) 8 (17.4%) 44 (39.6%) 
variable duration II 15 (46.9%) 0 (0.0%) 15 (13.5%) 
all 32 (100%) 46 (100%) 111 (100%) 
 
* Note that in one study reporting on both ni-EVD and i-EVD no information could be retrieved which EEG changes applied to the ni-EVD 
and which applied to the i-EVD cases.60 These 46 (ni-EVD: 33; i-EVD: 13) cases are therefore excluded from this part of the data analysis. 
† In the study by Erkwoh60 16 cases with EVD of mostly (13/16) temporal lobe origin could not be separated into ni-EVD and i-EVD, 
therefore these cases are not included in the subgroup (ni-EVD and i-EVD) analysis. 
‡ In 32 cases, epileptic discharges were localized to more than one of the four principal lobes, in these cases one count was given to each 
area (this included temporo-parietal, temporo-occipital, fronto-temporal, parieto-occipital and temporo-parieto-occipital locations). 
Accordingly, the total number of counts exceeded the number of patients with EVD by 41. 
§ Duration of episodes in individual subjects ranging from seconds to minutes. We noted reports of EVD lasting “several hours” in 8 patients 
from a single study.47 
II A distinction between ni-EVD and i-EVD was possible only in part of the patients. Only these patients are reported in the ni-EVD and i-
EVD columns, while all patients are considered in the "all" column. 
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Table 6: accompanying seizure symptoms in EVD patients *, † 
Sensory phenomena 133 
cephalic sensations (pressure, heat, pain) 61 
visual hallucinations 32 
auditory hallucinations 23 
simple (tinnitus, sounds, dysacusis) 19 
complex (music, voices etc…) 4 
somatosensory, excluding cephalic sensations 16 
olfactory hallucinations 1 
Motor symptoms 120 
focal motor seizures 28 
generalized tonic-clonic seizures 25 
arrest (speech, activity) 22 
falls 14 
automatisms 12 
head deviation 8 
nystagmus 8 
verbal (screaming, vocalization) 3 
Disturbances of consciousness 104 
transient loss of consciousness 45 
emotional (fear, anxiety, agitation) 16 
emergence of an idea 15 
loss of contact 11 
dysmnestic (e.g. déja-vu) 6 
conscious confusion 5 
aphasia 4 
disturbance of body image 2 
Autonomic / visceral phenomena 57 
vomiting 18 
nausea 12 
malaise / weakness 8 
epigastric (rising sensation) 6 
pallor 5 
thermoregulatory 5 
cardiovascular 2 
pulmonary 1 
 
* A total of 411 seizure symptoms were retrieved from 171 EVD patients (166 with ni-EVD and 5 with i-EVD where nystagmus was the 
only sign besides the symptom of vertigo / dizziness), therefore some patients had more than one seizure symptom in one or several groups, 
leading to several counts. 
 
† Note that only symptoms accompanying vertigo / dizziness, i.e. occurring during the same episode were considered and that in some 
studies information about symptoms was abstracted and therefore not available on the level of individual patients. 
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